 In each group, 21 subjects consume 100mg Resveratrol RSV and 150mg Epigallocatechin-gallate EGCG, respectively Placebo capsules, twice daily over a period of 12 weeks. The subjects receive the capsules after the last pre-measurement and continue to take them throughout the post-measurements. 